ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Two Private Cancer Information Services Are Up and Running

May 13, 1988

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

ONS Calls For Changes To Resolve Nurse Shortage

June 8, 2001

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

In Brief: Edward Sondik Named Director Of CDC’s National Center for Health Statistics

April 12, 1996

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

April 24, 1998